Brief: Nicox And Kowa Enter Into Agreement For Glaucoma Treatment

Nicox SA

08/02/2024 06:53

Feb 8 (Reuters) - Nicox SA  ALCOX.PA :
    * NICOX AND KOWA ENTER INTO AGREEMENT FOR NCX 470
DEVELOPMENT AND
COMMERCIALIZATION IN JAPAN
    * €3 MILLION UPFRONT PAYMENT AND A TOTAL OF A FURTHER
POTENTIAL
€27.5 MILLION IN MILESTONES
    * TIERED ROYALTIES ON NET SALES OF 7% TO 12%
    * UPFRONT PAYMENT EXTENDS NICOX CASH RUNWAY TO SEPTEMBER
2024
    * TO DEVELOP AND COMMERCIALIZE NCX 470, NICOX’S NITRIC OXIDE
(NO)-DONATING BIMATOPROST EYE DROP 
    * FOR THE LOWERING OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS
WITH
GLAUCOMA OR OCULAR HYPERTENSION

Source text for Eikon:  urn:newsml:reuters.com:*:nGNX4tDyGJ
Further company coverage:  ALCOX.PA 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))